Selectis Health files Rule 12b-25 late 10-Q notice

Selectis Health, Inc. notified the SEC under Rule 12b-25 that it could not timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 because it has not completed preparation of its unaudited financial statements.

Accepted by SEC EDGAR 05/14/2026 - 04:10 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Selectis Health, Inc. notified the SEC under Rule 12b-25 that it could not timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 because it has not completed preparation of its unaudited financial statements. The company signed the notice on May 14, 2026.

Key Figures

SEC File Number: 0-15415 CUSIP: 816291108 Period Ended: March 31, 2026 +3 more

6 metrics

SEC File Number 0-15415 cover data on notice

CUSIP 816291108 cover data on notice

Period Ended March 31, 2026 Quarter covered by the Form 10-Q

Notice Signed May 14, 2026 signature date on the 12b-25 notice

Registered Address 600 17th St., Suite 2800 principal executive office in Denver, CO

Contact Phone (303) 588-3978 Clifford L. Neuman, P.C. contact in Part IV

Key Terms

Rule 12b-25, Form 10-Q, unaudited financial statements, Notice of Late Filing

4 terms

Rule 12b-25 regulatory

"The Registrant is unable to file its Quarterly Report on Form 10-Q within the prescribed time period"

Rule 12b-25 is an SEC filing provision that lets a company notify regulators and the public that it cannot file a required periodic report (like a quarterly or annual report) on time and explains the reason for the delay. For investors, the notice is a formal heads-up that financial information will arrive late—similar to a company calling to say it will be late turning in homework—so it signals increased uncertainty and may affect trading and risk assessments until the filing is available.

Form 10-Q financial

"The Registrant is unable to file its Quarterly Report on Form 10-Q within the prescribed time period"

A Form 10-Q is a detailed report that publicly traded companies are required to file with regulators three times a year, providing an update on their financial health and business activities. It is important for investors because it offers timely insights into a company's performance, helping them make informed decisions about buying or selling stocks. Think of it as a regular check-up report that shows how well a company is doing.

unaudited financial statements financial

"has not completed the preparation of its unaudited financial statements"

Unaudited financial statements are company-prepared reports of financial activity—such as income, expenses, assets and liabilities—that have not been examined or certified by an independent auditor. They offer a quicker, internal snapshot of performance, like a homeowner’s informal monthly budget compared with a bank-verified tax return. Investors use them to track recent trends and short-term results, but they carry less external verification than audited statements.

Notice of Late Filing regulatory

"NOTICE OF LATE FILING (Check One)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did Selectis Health (GBCS) file a Rule 12b-25 notice?

They could not complete preparation of the unaudited financial statements required for the Form 10-Q. The notice states the delay is due to incomplete financial statement preparation for the quarter ended March 31, 2026.

When did Selectis Health (GBCS) sign the late filing notification?

The notice was signed on May 14, 2026 by an authorized officer. The filing identifies the company representative as Krystal Eckhard on that date.

Does the Rule 12b-25 notice state when the Form 10-Q will be filed?

The notice does not give a specific filing date for the Form 10-Q. It only states the reason for delay: the unaudited financial statements were not completed.

Will this Rule 12b-25 notice affect Selectis Health’s other recent SEC filings?

The notice includes a checkbox about other period reports and indicates whether prior reports were filed. It does not list any missed periodic reports in the provided excerpt.

Who is listed as the contact or preparer on the notice for Selectis Health (GBCS)?

The filing lists Clifford L. Neuman, P.C. with an address in Niwot, Colorado and phone number (303) 588-3978 in the Part IV contact section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

FORM 12b-25

SEC File Number 0-15415

CUSIP Number 816291108

NOTICE OF LATE FILING

(Check One):

☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR

For Period Ended: March 31, 2026

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A

Part I—Registrant Information

Full Name of Registrant: Selectis Health, Inc.

Former Name if Applicable:

Address of Principal Executive Office (Street and Number):

600 17^th St., Suite 2800

Denver, CO 80202

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Part II—Rules 12b-25(b) and (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12(b)-25(b), the following should be completed. (Check box if appropriate)

(a)	☐	The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
(b)	☒	The subject annual report or semi-annual report/portion thereof will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report/portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
(c)	☐	The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

Part III—Narrative

State below in reasonable detail the reasons why form 10-K, 11-K, 20-F, 10-Q or N-SAR or portion thereof could not be filed within the prescribed time period.

The Registrant is unable to file its Quarterly Report on Form 10-Q within the prescribed time period because the Company has not completed the preparation of its unaudited financial statements for the fiscal quarter.

Part IV—Other Information

(1) Name and telephone number of person to contact in regard to this notification

Clifford L. Neuman, P.C.

8300 Greenwood Dr.

Niwot, Colorado 80503

(303) 588-3978

(2)	Have all other period reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
	☒ Yes ☐ No
(3)	Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
	☐ Yes ☒ No

If so; attach an explanation of the anticipated change, both narratively and quantitively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

SELECTIS HEALTH, INC.

(Name of Registrant as specified in charter)

has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

Date:	May 14, 2026	By:	/s/ Krystal Eckhart
			Krystal Eckhard, VP